Dose Therapeutics is a biotechnology company that discovers and develops cutting-edge medicines for treating unmet medical needs.
Dose Therapeutics has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.
Dose Therapeutics is headquartered in Dallas, United States.
Dose Therapeutics is a biotechnology company that discovers and develops cutting-edge medicines for treating unmet medical needs.
Dose Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dose Therapeutics — Funding & Investors." VCBacked, May 11, 2022, https://www.vcbacked.co/company/dose-therapeutics. Accessed August 17, 2026.
VCBacked. (2022). Dose Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/dose-therapeutics
{{cite web |title=Dose Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dose-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated